Your browser doesn't support javascript.
Cytokine levels and pathological characteristics of a patient with severe coronavirus disease 2019: a case report.
Kang, Kai; Gao, Yang; Zhao, Mingyan; Fei, Dongsheng; Ye, Ming; Gao, Yan; Yang, Wei; Wang, Changsong; Liu, Haitao; Chang, Guangping; Kang, Xianxin; Luo, Yunpeng; Du, Xue; Qi, Jiping; Tian, Lin; Zhou, Min; Hao, Chunfang; Yu, Kaijiang.
  • Kang K; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Gao Y; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Zhao M; Institute of Critical Care Medicine, The Sino Russian Medical Research Center of Harbin Medical University, Harbin, Heilongjiang 150081, China.
  • Fei D; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Ye M; Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Harbin, Heilongjiang 150001, China.
  • Gao Y; The Cell Transplantation Key Laboratory of National Health Commission, Harbin, Heilongjiang 150001, China.
  • Yang W; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Wang C; Department of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
  • Liu H; Department of Critical Care Medicine, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Chang G; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Kang X; Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China.
  • Luo Y; Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, China.
  • Du X; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Qi J; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Tian L; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Zhou M; Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Hao C; Department of Pathology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
  • Yu K; Department of Pathology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
Chin Med J (Engl) ; 135(1): 101-103, 2021 06 01.
Article in English | MEDLINE | ID: covidwho-1254883
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cytokines / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Limits: Humans / Male / Middle aged Language: English Journal: Chin Med J (Engl) Year: 2021 Document Type: Article Affiliation country: CM9.0000000000001540

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Cytokines / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Limits: Humans / Male / Middle aged Language: English Journal: Chin Med J (Engl) Year: 2021 Document Type: Article Affiliation country: CM9.0000000000001540